Related Experiment Videos
IORT of carcinoma of the extrahepatic bile ducts
K Willborn1, W Sauerwein, J Erhard
1Department of Radiotherapy, Universitätsklinikum Essen, Germany.
Frontiers of Radiation Therapy and Oncology
|January 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2013
[Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2012
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011
Patient Journey and Treatment Patterns of Non-Muscle-Invasive Bladder Cancer in Mexico.
Current oncology (Toronto, Ont.)·2026
Opportunistic Cardiovascular Assessment During Lung Cancer Screening with Low-Dose Computed Tomography: A New Window for Prevention.
Advances in respiratory medicine·2026
Primary high-grade malignant epithelial-myoepithelial carcinoma of the lung: diagnostic pitfalls of a very rare lung malignancy.
Interdisciplinary cardiovascular and thoracic surgery·2026